FIBRINOGEN ANOMALIES AND DISEASE - A CLINICAL UPDATE

被引：26

作者：

GALANAKIS, DK ^{[1
]}

机构：

[1] SUNY STONY BROOK,SCH MED,DEPT PATHOL,STONY BROOK,NY 11794

来源：

关键词：

D O I：

10.1016/S0889-8588(18)30303-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1171 / 1187

页数：17

共 104 条

[1] ALMONDHIRY H, 1987, J LAB CLIN MED, V110, P726
[2] FIBRINOGEN GIESSEN-I - A CONGENITAL HOMOZYGOUSLY EXPRESSED DYSFIBRINOGENEMIA WITH A-ALPHA 16-ARG-] HIS SUBSTITUTION
ALVING, BM
HENSCHEN, AH
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 1987, 25 (04) : 479 - 482
[3] BELITZER WA, 1952, BIOKHIMIYA, V17, P676
[4] BLOMBACK B, 1988, FIBRINOGEN, V3, P263
[5] BOWIE EJW, 1963, J LAB CLIN MED, V62, P416
[6] BUDZYNSK.AZ, 1974, J BIOL CHEM, V249, P2294
[7] BUDZYNSKI AZ, 1974, BLOOD, V44, P950
[8] CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[9] INHIBITION OF FIBRIN MONOMER POLYMERIZATION BY LAMBDA MYELOMA GLOBULINS
COLEMAN, M
WEKSLER, ME
VIGLIANO, EM
NACHMAN, RL
[J]. BLOOD-THE JOURNAL OF HEMATOLOGY, 1972, 39 (02): : 210 - &
[10] CONLON CL, 1978, 17 P C INT SOC HEM, P937